# rFIP-nha activates macrophages towards a pro-inflammatory phenotype via AIM2 inflammasome modulation

**Authors:** Yusi Liu, Zhen Li, Harry Wichers, Shanna Bastiaan-Net, Tamara Hoppenbrouwers

PMC · DOI: 10.3389/fcell.2025.1533742 · Frontiers in Cell and Developmental Biology · 2025-04-28

## TL;DR

A fungal protein called rFIP-nha activates macrophages to behave pro-inflammatorily by modulating the AIM2 inflammasome.

## Contribution

The study reveals that rFIP-nha activates macrophages via the AIM2 inflammasome, independent of glycosylation.

## Key findings

- rFIP-nha and its glycan mutants induce pro-inflammatory cytokine secretion in THP-1 macrophages.
- AIM2 inflammasome is 10-fold upregulated and essential for IL-1β release induced by rFIP-nha.
- Glycosylation does not significantly affect the immunomodulatory activity of rFIP-nha.

## Abstract

Fungal immunomodulatory proteins (FIPs) are small proteins from fungi with considerable immunomodulatory activity. FIP-nha (Nectria haematococca) contains two glycosylation sites at positions N5 and N39, and displays a high thermostability and notable anti-tumour activity. However, FIP-nha’s immunomodulatory activity on macrophages and the associated mechanism remain unclear. In this study, three rFIP-nha glycan mutants (N5A, N39A, N5+39A) were recombinantly expressed in Pichia pastoris. To test the impact on FIP-nha’s immunomodulatory activity, the phagocytotic activity, cytokine secretion, and gene expression of THP-1 macrophages were investigated. rFIP-nha and its mutants reduced macrophage phagocytosis, and induced IL-1β, IL-12 and IL-10 cytokine secretion significantly, indicating that the protein confers a pro-inflammatory behaviour on THP-1 macrophages. However, there were no obvious differences among the different glycan mutants, indicating that the observed activation mechanisms are likely glycosylation-independent. Furthermore, to study the immunomodulatory mechanism, four kinds of inflammasomes (NLRP1, NLRP3, NLRC4 and AIM2) were tested at transcriptional level. AIM2 was found to be 10-fold upregulated. Then, THP1-KO-ASC cells and AIM2 related inhibitors showed that IL-1β release induced by rFIP-nha is ASC signalling pathway dependent. Taken together, these findings suggest that rFIP-nha activates THP-1 macrophages in a pro-inflammatory way by activating the AIM2 inflammasome.

## Linked entities

- **Genes:** AIM2 (absent in melanoma 2) [NCBI Gene 9447], NLRP1 (NLR family pyrin domain containing 1) [NCBI Gene 22861], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], NLRC4 (NLR family CARD domain containing 4) [NCBI Gene 58484], STS (steroid sulfatase) [NCBI Gene 412]
- **Proteins:** IL1B (interleukin 1 beta), IL12 (Interleukin 12 level), IL10 (interleukin 10)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249), tumour (MESH:D009369)
- **Chemicals:** FIP-nha (-)
- **Species:** Nectria haematococca [taxon 140110]
- **Mutations:** N39, N39A
- **Cell lines:** THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12066430/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12066430/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12066430/full.md

---
Source: https://tomesphere.com/paper/PMC12066430